Business

What a Bristol-Myers Squibb project says about the future of A.I.

Published

3 years ago

on

25 January 2022

By

Terry Power

Using A.I. to spot “off-label” drug prescribing | Fortune

You need to enable JavaScript to view this site.

Related Topics:Abuse ai artificial intelligence big data brain-inspired AI Brian Dreyfus bristol myers squibb BristolMyers Cortical.io drug surveillance Drugs eye on a.i.Future machine learning medicines natural language processing neuroscience off-label off-label prescribing post-market surveillance Project semantic folding side effects small data Squibb Taylor Peer ultra-large language models